Delivery Order SPE2DB24D2013-SPE2DB24FCHQS

Award Date 9/18/24
Potential Completion Date 9/19/24
Potential Value $7.5K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,086.08 firm-fixed-price delivery order is for LINZESS 290 MCG CAPSULE UU 30S, a pharmaceutical product. The contract has an ultimate completion date of June 17, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The award is a Delivery Order contract for $1,087.92 to supply LINZESS 145 MCG capsules. The contract has a completion date of June 21, 2024 and is a Firm Fixed Price arrangement. Amerisourcebergen, a major pharmaceutical distributor, holds a large Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 through 2025 with DLA Troop Support Medical. This...
This federal contract award to Amerisourcebergen Drug Corp (a subsidiary of Amerisourcebergen Corporation) is for the delivery of LINZESS 145 MCG CAPSULE UU 30S pharmaceutical products to the Defense Logistics Agency (DLA), a defense agency within the U.S. Department of Defense. The contract is a Delivery Order with a Firm Fixed Price pricing type, valued at $1,169.48, and has an ultimate completion date of May 31, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,400.96 Firm Fixed Price delivery order contract is for the supply of the medication LINZESS 145 MCG CAPSULE UU 30S. The contract has an ultimate completion date of May 9, 2025. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,573.33 Firm Fixed Price Delivery Order is for the supply of LINZESS 145 MCG CAPSULE, a pharmaceutical product, with a completion date of July 18, 2022. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This is a Firm Fixed Price Delivery Order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,861.49, is for the delivery of the pharmaceutical product LINZESS 145 MCG CAPSULE UU 30S. The award has an ultimate completion date of January 10, 2023. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,505.54 fixed-price delivery order is for the supply of LINZESS 290 MCG capsules. The contract has a completion date of December 9, 2022 and was awarded on December 8, 2022. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,907.91 firm-fixed-price delivery order is for the supply of LINZESS 72 MCG CAPSULE UU 30S, a prescription medication. The award has an ultimate completion date of June 23, 2023. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,181.94 Firm Fixed Price Delivery Order is for the supply of LINZESS 290 MCG CAPSULE UU 30S, a pharmaceutical product. The contract has an ultimate completion date of July 2, 2025 and was awarded on July 1, 2025. The award is not set aside and represents open competition. Amerisourcebergen Drug Corp holds a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,380.19 firm fixed-price delivery order is for the supply of the medication LINZESS 72 MCG CAPSULE UU 30S. The contract has an ultimate completion date of November 15, 2024 and does not have a set-aside designation. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the...
  • SPE2DB24D2013
    Indefinite Delivery Contract
  • SPE2DB24D2013-SPE2DB24FCHQS
    Delivery Order

This federal contract award to Amerisourcebergen Drug Corp, Corporate Office Division, provides for the delivery of LINZESS 290 MCG CAPSULE UU 30S to the Defense Logistics Agency (DLA). The $7,473.57 firm-fixed-price delivery order has an ultimate completion date of September 19, 2024. Amerisourcebergen is a major pharmaceutical distributor that holds an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999, to deliver a wide range of medical commodities to support military treatment programs and facilities worldwide. The company also holds an IDC with the Department of Justice Federal Bureau of Investigation, valued at up to $750,000, for similar medical products and prescription drugs. This particular award is not set aside and is part of Amerisourcebergen's extensive federal contracting activities to supply essential pharmaceutical and medical supplies to various defense and civilian government agencies.

Generated 12/18/24, 9:20 AM